Insider filing · MDGL
Kenneth Bate
Director
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 60 filings in 24 months
ticker →
Kenneth Bate sold $6.9M of Madrigal Pharmaceuticals (MDGL)
Executed Feb 27 2025, disclosed Feb 28 2025, 1 day later.
Value, as filed
$6.9M
19,446 sh across 6 lots
Executed
Feb 27 2025
the trade date, as filed
Disclosed
Feb 28 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KBKenneth Bate (Director) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $8.0M of MDGL (16,545 sh across 10 lots, as filed), executed Nov 5 2025.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kenneth Bate in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$8.0M16,545 sh across 10 lots
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $3.7M
10,000 sh across 6 lots
Exec Aug 15 2025
Filed Aug 15 2025 · 5:30 PM ET